Cart 0 Product Products (empty)
No products
To be determined Shipping
0,00 € Total
Prices are tax excluded
Product successfully added to your shopping cart
Quantity
Total
There are 0 items in your cart. There is 1 item in your cart.
Total products (tax excl.)
Total shipping (tax excl.) To be determined
Total (tax excl.)
Data sheet of IL4 polyclonal antibody
| Brand | Abnova |
| Product type | Primary antibodies |
| Reactivity | Human,Mouse,Rat |
| Host species | Rabbit |
| Applications | ELISA,IHC-P |
More info about IL4 polyclonal antibody
| Brand: | Abnova |
| Reference: | PAB16160 |
| Product name: | IL4 polyclonal antibody |
| Product description: | Rabbit polyclonal antibody raised against IL4. |
| Isotype: | IgG |
| Gene id: | 3565 |
| Gene name: | IL4 |
| Gene alias: | BCGF-1|BCGF1|BSF1|IL-4|MGC79402 |
| Gene description: | interleukin 4 |
| Immunogen: | Human IL4. |
| Protein accession: | P05112 |
| Form: | Liquid |
| Recommend dilutions: | ELISA (1-2 ug/mL) Immunohistochemistry (2-10 ug/mL) The optimal working dilution should be determined by the end user. |
| Storage buffer: | In TBS, pH 7.4 (50% glycerol, 1% BSA, 0.03% proclin). |
| Storage instruction: | Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
| Product type: | Primary antibodies |
| Host species: | Rabbit |
| Antigen species / target species: | Human |
| Reactivity: | Human,Mouse,Rat |
| Application image: |  |
| Application image note: | Immunohistochemical analysis of IL4 expression in paraffin fixed human esophageal squamous cell carcinoma (ESCC). Using IL4 polyclonal antibody (Cat # PAB16160). |
| Applications: | ELISA,IHC-P |
| Shipping condition: | Dry Ice |
| Publications: | Immune modulation of a novel lipid-soluble extract of Pinellia pedatisecta Schott in the tumor microenvironment of an HPV+ tumor-burdened mouse model.Huang H, Zhang M, Zhang M, Peng J; with the Pinellia pedatisecta (PE) advisory group; Based on a consultative process of researchers active in tumor immunology and with particular input by the PE Advisory group:, Li G, Xu C, Gui S. J Ethnopharmacol. 2018 May 19;225:103-115. |